- Home
- SAN vs TMO Comparison
SAN vs TMO Comparison
Compare SAN & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SAN | TMO |
|---|---|---|
| Founded | 1857 | 1956 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.8B | 216.4B |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | SAN | TMO |
|---|---|---|
| Price | $12.19 | $541.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 19 |
| Target Price | N/A | ★ $639.83 |
| AVG Volume (30 Days) | ★ 10.5M | 2.7M |
| Earning Date | 02-04-2026 | 01-29-2026 |
| Dividend Yield | ★ 1.51% | 0.32% |
| EPS Growth | ★ 23.93 | 7.32 |
| EPS | 1.12 | ★ 17.74 |
| Revenue | ★ $58,681,460,631.00 | $44,556,000,000.00 |
| Revenue This Year | $23.30 | $5.50 |
| Revenue Next Year | N/A | $5.52 |
| P/E Ratio | ★ $10.94 | $30.57 |
| Revenue Growth | N/A | ★ 3.91 |
| 52 Week Low | $5.51 | $385.46 |
| 52 Week High | $13.11 | $643.99 |
Technical Indicators
Market Signals| Indicator | SAN | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 28.13 |
| Support Level | $12.12 | $541.34 |
| Resistance Level | $13.11 | $588.85 |
| Average True Range (ATR) | 0.32 | 14.68 |
| MACD | -0.06 | -10.06 |
| Stochastic Oscillator | 55.21 | 0.72 |
Price Performance
Historical ComparisonAbout SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).